scholarly journals Adjuvant treatment of HER2-positive breast cancer: winning efforts continue to improve HER2-positive patient outcome long-term

2012 ◽  
Vol 14 (2) ◽  
Author(s):  
Rachel C Jankowitz ◽  
Adam M Brufsky
Keyword(s):  
Breast Cancer ◽  
Patient Outcome ◽  
Adjuvant Treatment ◽  
Positive Patient ◽  
Her2 Positive ◽  
Her2 Positive Breast Cancer ◽  
Positive Breast Cancer

scholarly journals Long-term trastuzumab (Herceptin®) treatment in a continuation study of patients with HER2-positive breast cancer or HER2-positive gastric cancer

BMC Cancer ◽  
2018 ◽  
Vol 18 (1) ◽  
Author(s):  
Volkmar Müller ◽  
Michael Clemens ◽  
Jacek Jassem ◽  
Nedal Al-Sakaff ◽  
Petra Auclair ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Gastric Cancer ◽  
Her2 Positive ◽  
Her2 Positive Breast Cancer ◽  
Positive Breast Cancer

scholarly journals The Effect of Adjuvant Treatment in Small Node-negative HER2-positive Breast Cancer: Which Subgroup Will Benefit?

2020 ◽  
Vol 20 (6) ◽  
pp. 503-510
Author(s):  
Haiping Lin ◽  
Hongjuan Zheng ◽  
Chenyang Ge ◽  
Qinghua Wang ◽  
Wanfen Tang ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Adjuvant Treatment ◽  
Her2 Positive ◽  
Node Negative ◽  
Her2 Positive Breast Cancer ◽  
Positive Breast Cancer

scholarly journals Long-term cardiac outcomes of patients with HER2-positive breast cancer treated in the adjuvant lapatinib and/or trastuzumab Treatment Optimization Trial

2020 ◽  
Vol 122 (10) ◽  
pp. 1453-1460 ◽  
Author(s):  
Daniel Eiger ◽  
Noam F. Pondé ◽  
Dominique Agbor-Tarh ◽  
Alvaro Moreno-Aspitia ◽  
Martine Piccart ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Treatment Optimization ◽  
Her2 Positive ◽  
Trastuzumab Treatment ◽  
Her2 Positive Breast Cancer ◽  
Cardiac Outcomes ◽  
Positive Breast Cancer

Trastuzumab in combination with weekly paclitaxel and carboplatin as neo-adjuvant treatment for HER2-positive breast cancer: The TRAIN-study

2017 ◽  
Vol 74 ◽  
pp. 47-54 ◽  
Author(s):  
Mette S. van Ramshorst ◽  
Erik van Werkhoven ◽  
Ingrid A.M. Mandjes ◽  
Margaret Schot ◽  
Jelle Wesseling ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Adjuvant Treatment ◽  
Weekly Paclitaxel ◽  
Her2 Positive ◽  
Her2 Positive Breast Cancer ◽  
Positive Breast Cancer

scholarly journals Lack of acquired resistance in HER2-positive breast cancer cells after long-term HER2 siRNA nanoparticle treatment

PLoS ONE ◽  
2018 ◽  
Vol 13 (6) ◽  
pp. e0198141 ◽  
Author(s):  
Shenda Gu ◽  
Worapol Ngamcherdtrakul ◽  
Moataz Reda ◽  
Zhi Hu ◽  
Joe W. Gray ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Cells ◽  
Breast Cancer Cells ◽  
Acquired Resistance ◽  
Her2 Positive ◽  
Her2 Positive Breast Cancer ◽  
Positive Breast Cancer
Sign in / Sign up

Export Citation Format

Share Document